Corporate Update, August 2025
Provided By GlobeNewswire
Last update: Aug 4, 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) --
From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM)
Dear Shareholders,
Thank you for your continued support as we advance our mission to develop safe, effective, and naturally derived psychedelic therapies for people living with serious mental health challenges.
Read more at globenewswire.comNASDAQ:PBM (10/14/2025, 12:20:29 PM)
3.43
-0.13 (-3.65%)
Find more stocks in the Stock Screener
PBM Latest News and Analysis
